Ovitrelle 250mcg Pre-Filled Pen

Price range: £80.00 through £240.00

Ovitrelle 250mcg pre-filled pen (HCG) for clinician-approved treatment. Prescription only. Supplied following consultation and medical approval.

Start Assessment

Ovitrelle 250mcg pre-filled pen contains choriogonadotropin alfa (HCG), a hormone that mimics the action of luteinising hormone (LH) in the body. Clinicians prescribe this treatment for specific hormone-related conditions where HCG therapy is clinically appropriate. This is a prescription-only medicine, and you must complete a medical consultation before a registered clinician approves supply.

How This Treatment Works

Choriogonadotropin alfa binds to LH receptors and stimulates hormonal pathways involved in reproductive function. As a result, it supports natural processes that depend on luteinising hormone activity. Because it acts in a targeted way, clinicians use it within structured and carefully monitored treatment plans.

The pre-filled pen delivers a fixed 250 microgram dose via subcutaneous injection. Therefore, it allows accurate administration when used as instructed. Your clinician will explain how and when to administer the injection and will determine the appropriate schedule based on your individual treatment plan.

Who This Medicine Is For

This medicine is prescribed for patients whose clinician determines that HCG therapy is suitable based on medical history, examination findings and relevant blood tests. Suitability depends on individual assessment, and not all patients will be appropriate for treatment.

During your consultation, a clinician will review your overall health and treatment goals. Consequently, therapy remains personalised and clinically justified. Ongoing monitoring may be required depending on your indication and response to treatment.

Treatment Duration and Monitoring

The listed price is per pen. One device typically covers approximately 2–3 weeks, depending on the prescribed regimen. However, your clinician will determine the exact dosing frequency and duration of therapy.

Because hormone treatment requires supervision, you should attend all scheduled follow-up appointments and report any unexpected symptoms promptly. Always read the patient information leaflet carefully before starting treatment so you understand correct administration and safety advice.

Directions

Use Ovitrelle 250mcg pre-filled pen exactly as prescribed by your clinician.

  • Administer by subcutaneous injection as directed
  • Follow the prescribed dosing schedule carefully
  • Do not exceed the recommended dose
  • Dispose of needles safely in an appropriate sharps container

Your clinician will advise you on correct injection technique before treatment begins.

Ingredients

Active ingredient: Choriogonadotropin alfa 250 micrograms per pre-filled pen.

Please refer to the patient information leaflet for the full list of excipients.

Side Effects

Like all medicines, Ovitrelle 250mcg pre-filled pen can cause side effects, although not everyone experiences them.

  • Injection site reactions
  • Headache
  • Abdominal discomfort
  • Nausea
  • Mood changes

Seek medical attention immediately if you experience severe abdominal pain, shortness of breath, or signs of an allergic reaction.

Warnings

Ovitrelle 250mcg pre-filled pen is a prescription-only medicine and requires medical supervision. Only begin treatment after a clinician determines it is appropriate for you.

Inform your clinician before starting Ovitrelle 250mcg pre-filled pen if you:

  • Have a history of hormone-sensitive conditions
  • Have unexplained vaginal bleeding
  • Have ovarian enlargement or cysts
  • Have blood clotting disorders

Regular monitoring may be required during treatment depending on your clinical indication.